1. Home
  2. BCHT vs NEPH Comparison

BCHT vs NEPH Comparison

Compare BCHT & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BCHT

Birchtech Corp. Common Stock

N/A

Current Price

$2.27

Market Cap

56.5M

Sector

Industrials

ML Signal

N/A

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$3.99

Market Cap

45.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCHT
NEPH
Founded
N/A
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.5M
45.3M
IPO Year
2026
2004

Fundamental Metrics

Financial Performance
Metric
BCHT
NEPH
Price
$2.27
$3.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$15.00
$6.00
AVG Volume (30 Days)
155.6K
41.5K
Earning Date
N/A
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
106.67
EPS
N/A
0.10
Revenue
N/A
$14,162,000.00
Revenue This Year
$7.24
$33.32
Revenue Next Year
$7.10
$12.27
P/E Ratio
N/A
$39.00
Revenue Growth
N/A
N/A
52 Week Low
$2.20
$1.49
52 Week High
$2.45
$6.42

Technical Indicators

Market Signals
Indicator
BCHT
NEPH
Relative Strength Index (RSI) N/A 45.14
Support Level N/A $3.48
Resistance Level N/A $4.27
Average True Range (ATR) 0.00 0.35
MACD 0.00 0.03
Stochastic Oscillator 0.00 48.57

Price Performance

Historical Comparison
BCHT
NEPH

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: